Brainstorm Cell Therapeutics (BCLI) Total Non-Current Liabilities (2013 - 2025)
Brainstorm Cell Therapeutics' Total Non-Current Liabilities was $11.01 million in Q4 2025, compared with $618,000 a year earlier.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Total Non-Current Liabilities (2013 - 2025) Analysis & Trends
From Q4 2013 onward, Brainstorm Cell Therapeutics has reported Total Non-Current Liabilities for 33 quarters.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
- In earlier years, Total Non-Current Liabilities was $618,000 in FY2024 (-51.2%), $1.27 million in FY2023 (-52.5%), $2.67 million in FY2022 (-26.3%) and $3.62 million in FY2021 (-20.7%).
- The Q4 2025 figure marks the highest quarterly Total Non-Current Liabilities in data going back to Q4 2013.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was Q2 2021 (growth of 616.3%); the worst was Q3 2025 (a decline of 95.0%).
- Per Business Quant data, BCLI's Total Non-Current Liabilities in the three quarters before Q4 2025 was $50,000 (Q3 2025), $95,000 (Q2 2025) and $127,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.52 Bn | 1,126.11 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 631.39 Bn | 549.92 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 498.93 Bn | 472.04 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 376.05 Bn | 330.42 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 301.98 Bn | 265.97 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 265.05 Bn | 238.74 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 240.27 Bn | 195.67 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 193.08 Bn | 167.27 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.85 Bn | 118.50 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Brainstorm Cell Therapeutics | 8.72 Mn | 8.65 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 11.01 Mn |
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 127,000.00 |
| Dec 31, 2024 | 618,000.00 |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.94 Mn |
| Jun 30, 2023 | 1.94 Mn |
| Mar 31, 2023 | 2.29 Mn |
| Dec 31, 2022 | 2.67 Mn |
| Sep 30, 2022 | 2.92 Mn |
| Jun 30, 2022 | 3.26 Mn |
| Mar 31, 2022 | 3.93 Mn |
| Dec 31, 2021 | 3.62 Mn |
| Sep 30, 2021 | 3.77 Mn |
| Jun 30, 2021 | 4.00 Mn |
| Mar 31, 2021 | 4.18 Mn |
API Access
Brainstorm Cell Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();